2021-2032 All Rights Reserved. Online Journal of Veterinary Research. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under International copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editor.


Online Journal of Veterinary Research

(Including Medical and Laboratory Research)

Established 1994
ISSN 1328-925X


 Volume 25 (9):631-652, 2021.

Pharmacology of Astragalus polysaccharides for Veterinary therapeutics.


Li Hongquan


College of Veterinary Medicine and Animal Science, Shanxi Agricultural University, Taigu, Shanxi 030801, PRC, China.




Hongquan L., Pharmacology of Astragalus polysaccharides in Veterinary therapeutics, Onl J Vet Res., 25 (9):631-652, 2021. Radix Astragali has been used as a tonic, hepato-protective, diuretic, antiperspirant, expectorant and sedative. Astralagus derives from dried roots of Astragalus membranaceus, A. mongholious, and A. membranaceus. Ingredients associated with bioactivity in R Astragali include polysaccharides, saponins, lavonoids, alkaloids, amino acids, linoleic acid, and trace elements. Studies suggest that these constituents possess anti-aging, antioxidant, hypertensive, cancer, diabetic, stress, immunomodulatory, microbial and protozoal properties but recently newer active components have been found. Although R. Astragali has a long history of medicinal use chemo-pharmacological properties and clinical applications have not been described and mechanisms of action are not completely understood. Author reports recent advances in the pharmacology of Astragalus polysaccharide (APS) for Veterinary use.

Key words: Pharmacology; Immunology; Astragalus Polysaccharides (APS); Animals